Infliximab

Last Updated: 11/08/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20284 publications

Adjunctive infliximab for paradoxical reactions and immune reconstitution inflammatory syndrome in central nervous system tuberculosis: a scoping review.

Adjunctive infliximab for paradoxical reactions and immune reconstitution inflammatory syndrome in central nervous system tuberculosis: a scoping review.

Journal: Expert review of anti-infective therapy

Published: October 30, 2026

Review Article: A Scientific Journey with Zelig Eshhar at the Dawn of Monoclonal Antibody Research.

Review Article: A Scientific Journey with Zelig Eshhar at the Dawn of Monoclonal Antibody Research.

Journal: Critical reviews in oncogenesis

Published: October 30, 2026

A case of paradoxical pustular psoriasis and alopecia of the scalp caused by infliximab in a patient affected by Crohn disease.

A case of paradoxical pustular psoriasis and alopecia of the scalp caused by infliximab in a patient affected by Crohn disease.

Journal: Italian journal of dermatology and venereology

Published: October 29, 2026

Severe peripheral oedema temporally associated with accelerated infliximab induction for acute severe ulcerative colitis.

Severe peripheral oedema temporally associated with accelerated infliximab induction for acute severe ulcerative colitis.

Journal: BMJ case reports

Published: October 29, 2026

Uncovering the full economic impact of biosimilars: a "would have spent" counterfactual analysis of five reference biologics (infliximab, adalimumab, bevacizumab, rituximab, and trastuzumab) in the United States and Europe, 2016-2025.

Uncovering the full economic impact of biosimilars: a "would have spent" counterfactual analysis of five reference biologics (infliximab, adalimumab, bevacizumab, rituximab, and trastuzumab) in the United States and Europe, 2016-2025.

Journal: Journal of medical economics

Published: October 28, 2026

Biosimilars in inflammatory bowel disease: from initial uncertainty to clinical normalization.

Biosimilars in inflammatory bowel disease: from initial uncertainty to clinical normalization.

Journal: Revista espanola de enfermedades digestivas

Published: October 26, 2026

Perianal fistulizing Crohn's disease increases infliximab clearance and causes low infliximab exposure (ATLANTIC).

Perianal fistulizing Crohn's disease increases infliximab clearance and causes low infliximab exposure (ATLANTIC).

Journal: Journal of Crohn's & colitis

Published: October 23, 2026

Review: optimizing rescue therapy in acute severe ulcerative colitis using infliximab pharmacokinetics-a practical guide for clinicians.

Review: optimizing rescue therapy in acute severe ulcerative colitis using infliximab pharmacokinetics-a practical guide for clinicians.

Journal: Journal of Crohn's & colitis

Published: October 23, 2026

Advancing Our Understanding of Hidradenitis Suppurativa: A Comprehensive Guide for Clinicians Designed to Improve Therapeutic Outcomes for Patients-Part 2.

Advancing Our Understanding of Hidradenitis Suppurativa: A Comprehensive Guide for Clinicians Designed to Improve Therapeutic Outcomes for Patients-Part 2.

Journal: The Journal of clinical and aesthetic dermatology

Published: October 17, 2026

Tofacitinib 20 vs 30 mg in acute severe ulcerative colitis: a double-blind randomized controlled trial.

Tofacitinib 20 vs 30 mg in acute severe ulcerative colitis: a double-blind randomized controlled trial.

Journal: Journal of Crohn's & colitis

Published: October 15, 2026

Tumor Necrosis Factor-Alpha Inhibitors: Oral Health and Orthodontic Considerations.

Tumor Necrosis Factor-Alpha Inhibitors: Oral Health and Orthodontic Considerations.

Journal: Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)

Published: October 13, 2026

TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response.

TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response.

Journal: Cell metabolism

Published: October 13, 2026

Showing 1-12 of 20,284

Last Updated: 11/08/2026